GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
125 hedge funds and large institutions have $434M invested in G1 Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
64% less call options, than puts
Call options by funds: $2.54M | Put options by funds: $7.12M
Holders
125
Holding in Top 10
1
Calls
$2.54M
Puts
$7.12M
Top Buyers
| 1 | +$6.66M | |
| 2 | +$6.26M | |
| 3 | +$5.36M | |
| 4 |
BlackRock
New York
|
+$4.73M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$4.31M |
Top Sellers
| 1 | -$60.6M | |
| 2 | -$31.5M | |
| 3 | -$8.54M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$8.34M |
| 5 |
Millennium Management
New York
|
-$7.44M |